Share Email Print

Proceedings Paper

Multiphoton imaging of upconverting lanthanide nanoparticles in three dimensional models of cancer
Author(s): Christian F. Gainer; Marek Romanowski
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

While upconverting lanthanide nanoparticles have numerous advantages over other exogenous contrast agents used in scanned multiphoton imaging, their long luminescence lifetimes cause images collected with non-descanned detection to be greatly blurred. We demonstrate herein the use of Richardson-Lucy deconvolution to deblur luminescence images obtained via multiphoton scanning microscopy. Images were taken of three dimensional models of colon and ovarian cancer following incubation with NaYF4:Yb,Er nanoparticles functionalized with an antibody for EGFR and folic acid respectively. Following deconvolution, images had a lateral resolution on par with the optimal performance of the imaging system used, ~1.2 μm, and an axial resolution of ~5 μm. Due to the relatively high multiphoton excitation efficiency of these nanoparticles, it is possible to follow binding of individual particles in tissue. In addition, their extreme photostability allows for prolonged imaging without significant loss in luminescence signal. With these advantageous properties in mind, we also discuss the potential application of upconverting lanthanide nanoparticles for tracking of specific, cancer relevant receptors in tissue.

Paper Details

Date Published: 22 February 2013
PDF: 8 pages
Proc. SPIE 8595, Colloidal Nanocrystals for Biomedical Applications VIII, 85950O (22 February 2013); doi: 10.1117/12.2002551
Show Author Affiliations
Christian F. Gainer, The Univ. of Arizona (United States)
Marek Romanowski, The Univ. of Arizona (United States)

Published in SPIE Proceedings Vol. 8595:
Colloidal Nanocrystals for Biomedical Applications VIII
Wolfgang J. Parak; Marek Osinski; Kenji Yamamoto, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?